Macroeconomic Forces Driving Clinical Trial Costs

Dec 4, 2013

A lot has been written about the Affordable Care Act (ACA) recently. Key provisions are kicking in over the next few months and that has left everyone asking the same question — How will the ACA affect healthcare costs in ...

Read More

The Role of Central Laboratories in AD Trials

Dec 4, 2013

Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder that mainly affects the elderly population. The prevalence of AD is predicted to increase to 115.4 million by 2050. Tatiana Souslova at ACM Global Central Lab looks into why despite having the first ...

Read More

H7N9 Influenza and the Rush to Vaccine Development

Dec 4, 2013

On March 31, 2013, the Chinese health authorities announced the first human case of a new strain of avian influenza A virus H7N9. The announcement was repeated by the World Health Organization (WHO) the next day. By the end of ...

Read More